Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1706
| Despition | HPCAL1 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1223 | PAX8 Blocking Peptide (AC1223) | 250 µg | inquiry |
| ACPP-1309 | CCR5 Blocking Peptide (AC1309) | 250 µg | inquiry |
| ACPP-1519 | Human MANF Protein (AC1519) | 5 µg | inquiry |
| ACPP-1440 | Human SIRPA Protein (AC1440) | 5 µg | inquiry |
| ACPP-1130 | Native Bovine GFAP Protein (AC1130) | 25 µl | inquiry |
| ACPP-1072 | Synaptophysin Blocking Peptide (AC1072) | 250 µg | inquiry |
| ACPP-1400 | ACTH (AC1400) | 2 mg | inquiry |
| ACPP-1228 | Mouse IL 6 Protein (AC1228) | 2 µg | inquiry |
| ACPP-1438 | Human NDRG2 Protein (AC1438) | 5 µg | inquiry |
| ACPP-1128 | Recombinant Human Vimentin Protein (AC1128) | 25 µl | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.